Transdermal scopolamine as treatment of bradyarrhythmias.

  1. J Salas Nieto,
  2. J A Ruiperez Abizanda,
  3. F Pico Aracil,
  4. G de la Morena Valenzuela, and
  5. J A Ruiz Ros
  1. Servicio de Cardiología, Hospital de la Arrixaca, Murcia, Spain.

Abstract

Fifteen patients with different degrees of chronic bradyarrhythmias of supraventricular origin were studied with Holter monitoring before and during application of a transdermal patch of scopolamine. No changes were found in the mean or minimal heart rates, standard deviation of the RR interval, or the degree of bradyarrhythmia. It is concluded that transdermal scopolamine is not an adequate treatment of chronic symptomatic bradyarrhythmias.

« Previous | Next Article »Table of Contents

This Article

  1. doi: 10.1378/chest.101.6.1588 CHEST June 1992 vol. 101 no. 6 1588-1590

Current Issue

  1. January 2009, 135 (1)
  1. Alert me to new issues of CHEST

Most